Position in GILD
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$598,346
-$61,710 QoQ
Shares Held
4,736
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
#1,298
of 2,266 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026DELTA FINANCIAL ADVISORS LLC holds $17,401,793 across 7 Drug Manufacturers - General names. GILD ranks #7 (3.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
25,593 | $6,499,854 | |
| 2 | AMGN |
Amgen Inc
|
10,233 | $3,705,573 | |
| 3 | ABBV |
AbbVie Inc.
|
9,464 | $2,381,520 | |
| 4 | MRK |
Merck & Co., Inc.
|
16,179 | $2,079,001 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
26,459 | $1,524,567 | |
| 6 | PFE |
Pfizer Inc
|
25,454 | $612,932 | |
| 7 | GILD |
Gilead Sciences, Inc.
This page
|
4,736 | $598,346 |
All Filings in GILD
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $598,346 | 4,736 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $660,056 | 4,736 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $504,461 | 4,110 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $231,435 | 2,085 | Shares | Sole | 2025-10-30 | |
| No filing history on record for this holder in this stock. | ||||||